| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/20/2006 | EP1702916A1 DPP-IV inhibitors |
| 09/20/2006 | EP1702617A1 Cannabimimetic indole derivatives |
| 09/20/2006 | EP1702615A1 Glucose tolerance-improving agent |
| 09/20/2006 | EP1701947A2 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
| 09/20/2006 | EP1701736A1 Therapeutic agents and uses therefor |
| 09/20/2006 | EP1701735A2 Use of hydroxylated amino acids for treating diabetes |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | EP1397148B1 Chromium/biotin treatment of dyslipidemia |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1292621B1 Compositions for treating autoimmune disease |
| 09/20/2006 | EP1051191B1 CD154 BLOCKADE THERAPY FOR PANCREATIC ISLET TISSUE TRANSPLANTATION in primates |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | EP0799037B1 Compositions for treating allergic rhinitis and other disorders comprising descarboethoxyloratadine |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835943A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/20/2006 | CN1835916A 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders |
| 09/20/2006 | CN1835913A Propionic acid derivatives useful in the treatment of lipid disorders |
| 09/20/2006 | CN1835912A Crystalline form of nateglinide |
| 09/20/2006 | CN1835762A Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 09/20/2006 | CN1835761A Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilisation of glycemia |
| 09/20/2006 | CN1835760A Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 09/20/2006 | CN1835759A Micronutrient supplement |
| 09/20/2006 | CN1835752A Multivitamin syrup for children or young adults |
| 09/20/2006 | CN1835747A Use of 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 09/20/2006 | CN1835741A Novel composition comprising rosiglitazone and another antidiabetic agent |
| 09/20/2006 | CN1834091A Sustituted Gly derivative for treating diabetes and adiposis |
| 09/20/2006 | CN1834087A Organo-iodine complex |
| 09/20/2006 | CN1833727A Use of Arab gum in setting up animal's model and lowering blood cholestenone |
| 09/20/2006 | CN1833706A Medicine for treating diabets onellitus and prepn. thereof |
| 09/20/2006 | CN1833705A Medicinal drip pills for treating hyperlipemia and prepn. thereof |
| 09/20/2006 | CN1833703A Medicine for treating peripheral nervous disease of diabets mellitus and prepn. method |
| 09/20/2006 | CN1833698A Medicine for treating glycuresis retinal disease and its prepn. method |
| 09/20/2006 | CN1833694A Snail calcium capsules |
| 09/20/2006 | CN1833668A Medicinal compsns. having cooperative action |
| 09/20/2006 | CN1833665A Mangosteen peel extracts, its extraction method and medicine use |
| 09/20/2006 | CN1833664A Pterigospermin capsules and prodn. method |
| 09/20/2006 | CN1833661A Spirulina chewing tablets and prepn. thereof |
| 09/20/2006 | CN1833658A Medicine for treatment of cardio-cerebral blood vessel diseases and diabetes, and its prepn. method |
| 09/20/2006 | CN1833657A Compound preparation for prevention and treatment adiposis and its prepn. method |
| 09/20/2006 | CN1833653A Application and prepn. process of shiyacha total flavone |
| 09/20/2006 | CN1833651A Xindakang drip pill and prepn. thereof |
| 09/20/2006 | CN1833640A Medicinal componds contg taurine |
| 09/20/2006 | CN1833639A 'Xindakang' dispersion tablets and prepn. method |
| 09/20/2006 | CN1833519A Health tea |
| 09/20/2006 | CN1275977C O-aryl glucoside SGL T2 inhibitors |
| 09/20/2006 | CN1275958C Genistein-3'-sodium sulfonate, dimethylation daidzein-3'-sodium sulfonate, their preparing process and pharmaceutical use |
| 09/20/2006 | CN1275942C Benzyloxy substituted indole compound and its analog and their production method and application |
| 09/20/2006 | CN1275940C New phenylalkyloxy-phenyl derivatives |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/20/2006 | CN1275643C Short peptide type nutriend emulsion inside bowel and producing method |
| 09/20/2006 | CN1275634C Health tea capable of reducing blood lipid, blood viscosity and blood pressure |
| 09/20/2006 | CN1275615C Levulose absorption retardant, compound, food and levulose absorption repressor |
| 09/20/2006 | CN1275605C Guibiegongjiang capsule and its preparation method |
| 09/20/2006 | CN1275597C System with extensible released drug containing extract of hawkthom leaves |
| 09/20/2006 | CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/20/2006 | CN1275551C Green healthy beverage |
| 09/20/2006 | CN1275545C Eatable ants and its preparation method |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109339 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/19/2006 | US7109330 {(2-hydroxyethyl)[9-(methylethyl)-6-(3-quinolylamino)purin-2-yl]amino}ethan-1-ol; antiproliferatives, treating rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, cancer, restenosis, host graft disease, and gout |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109226 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 09/19/2006 | US7109225 Substituted oxazole derivatives |
| 09/19/2006 | US7109222 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid; Hypercholesterolemia, hyperlipidemia, and diabetes |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109207 Used to treat metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109198 Method for treating obesity |
| 09/19/2006 | US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109189 Mitochondrially targeted antioxidants |
| 09/19/2006 | US7109174 Anticonvulsant derivatives useful for preventing the development of type II diabetes mellitus and syndrome X |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7108869 For limiting the absorption of carbohydrates contained in a foodstuff, for promoting weight loss in an individual |
| 09/19/2006 | CA2083396C Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them |
| 09/14/2006 | WO2006096564A1 Fused aromatic compounds having anti-diabetic activity |
| 09/14/2006 | WO2006095922A1 Tetrahydroisoquinoline compound and medicinal use thereof |
| 09/14/2006 | WO2006095870A1 Photosensitizer, protein-cleaving agent, method of cleaving protein, sugar molecule-cleaving agent, method of cleaving sugar molecule, and photodynamic therapeutic agent |
| 09/14/2006 | WO2006095822A1 Sulfonamide compound and pharmaceutical thereof |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |
| 09/14/2006 | WO2006095357A1 A synergistically heat stable oil media having eicosa pentaenoic acid (epa) and docosa hexaenoic acid (dha) |
| 09/14/2006 | WO2006094942A1 Roflumilast for the treatment of diabetes mellitus |
| 09/14/2006 | WO2006094933A1 Roflumilast for the treatment of diabetes mellitus |
| 09/14/2006 | WO2006094682A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/14/2006 | WO2006094674A1 Nmda receptor antagonists in the medical intervention of metabolic disorders |
| 09/14/2006 | WO2006094633A1 1- sulfonyl-pi perdine- 3 -carboxyl i c acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus |
| 09/14/2006 | WO2006094450A1 Medicaments and food for treatment or prevention of obesity and/or diabetes containing cicer arietinum extract |
| 09/14/2006 | WO2006086464A3 Dihydroquinazolinones as 5ht modulators |
| 09/14/2006 | WO2006086445A3 Combination therapy |
| 09/14/2006 | WO2006069153A3 Vitamin d receptor modulators |
| 09/14/2006 | WO2006068987A3 Uses of il-23 antagonists in the treatment of diabetes mellitus |
| 09/14/2006 | WO2006065582A3 Muteins of fibroblast growth factor 21 |
| 09/14/2006 | WO2006061336A3 Oral compositions for absorption of phosphorus compounds |
| 09/14/2006 | WO2006060535A3 Indole derivatives for use as ppar active compounds |
| 09/14/2006 | WO2006009465A3 Composition comprising protein material and non-oxidizable fatty acid entities |
| 09/14/2006 | WO2006009438A3 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
| 09/14/2006 | US20060205948 such as 2-(2-chloro-phenyl)-5-isopropyl-3-(3,4,5-trifluoro-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one; for treatment of eating disorders and psychological disorders |
| 09/14/2006 | US20060205931 Pharmaceutical compositions having appetite suppressant activity |